5-[(2,4-dichloro-5-pyridin-2-ylbenzoyl)amino]-N-[(3R,4S)-4-hydroxyoxolan-3-yl]-1-phenylpyrazole-3-carboxamide

C26H21Cl2N5O4 — CID 126963049

IUPAC5-[(2,4-dichloro-5-pyridin-2-ylbenzoyl)amino]-N-[(3R,4S)-4-hydroxyoxolan-3-yl]-1-phenylpyrazole-3-carboxamide
SMILESO=C(N[C@@H]1COC[C@H]1O)c1cc(NC(=O)c2cc(-c3ccccn3)c(Cl)cc2Cl)n(-c2ccccc2)n1
InChIInChI=1S/C26H21Cl2N5O4/c27-18-11-19(28)17(10-16(18)20-8-4-5-9-29-20)25(35)31-24-12-21(26(36)30-22-13-37-14-23(22)34)32-33(24)15-6-2-1-3-7-15/h1-12,22-23,34H,13-14H2,(H,30,36)(H,31,35)/t22-,23-/m1/s1
InChIKeyUFTQWQVOZWPVKL-DHIUTWEWSA-N
MW538.39 g/mol
LogP3.98
Rot. Bonds6

About 5-[(2,4-dichloro-5-pyridin-2-ylbenzoyl)amino]-N-[(3R,4S)-4-hydroxyoxolan-3-yl]-1-phenylpyrazole-3-carboxamide

5-[(2,4-dichloro-5-pyridin-2-ylbenzoyl)amino]-N-[(3R,4S)-4-hydroxyoxolan-3-yl]-1-phenylpyrazole-3-carboxamide (PubChem CID 126963049) has the molecular formula C26H21Cl2N5O4 and a molecular weight of 538.39 g/mol. Its IUPAC name is 5-[(2,4-dichloro-5-pyridin-2-ylbenzoyl)amino]-N-[(3R,4S)-4-hydroxyoxolan-3-yl]-1-phenylpyrazole-3-carboxamide.

Molecular Properties

Compound Name5-[(2,4-dichloro-5-pyridin-2-ylbenzoyl)amino]-N-[(3R,4S)-4-hydroxyoxolan-3-yl]-1-phenylpyrazole-3-carboxamide
PubChem CID126963049
Molecular FormulaC26H21Cl2N5O4
Molecular Weight538.39 g/mol
Exact Mass537.10
IUPAC Name5-[(2,4-dichloro-5-pyridin-2-ylbenzoyl)amino]-N-[(3R,4S)-4-hydroxyoxolan-3-yl]-1-phenylpyrazole-3-carboxamide
SMILESO=C(N[C@@H]1COC[C@H]1O)c1cc(NC(=O)c2cc(-c3ccccn3)c(Cl)cc2Cl)n(-c2ccccc2)n1
InChIInChI=1S/C26H21Cl2N5O4/c27-18-11-19(28)17(10-16(18)20-8-4-5-9-29-20)25(35)31-24-12-21(26(36)30-22-13-37-14-23(22)34)32-33(24)15-6-2-1-3-7-15/h1-12,22-23,34H,13-14H2,(H,30,36)(H,31,35)/t22-,23-/m1/s1
InChIKeyUFTQWQVOZWPVKL-DHIUTWEWSA-N
XLogP3.98
TPSA118.37 Ų
H-Bond Donors3
H-Bond Acceptors7
Rotatable Bonds6
Heavy Atoms37
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500538.39
LogP ≤ 53.98
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 107

Analyze 5-[(2,4-dichloro-5-pyridin-2-ylbenzoyl)amino]-N-[(3R,4S)-4-hydroxyoxolan-3-yl]-1-phenylpyrazole-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-[(2,4-dichloro-5-pyridin-2-ylbenzoyl)amino]-N-[(3R,4S)-4-hydroxyoxolan-3-yl]-1-phenylpyrazole-3-carboxamide?
The IUPAC name of 5-[(2,4-dichloro-5-pyridin-2-ylbenzoyl)amino]-N-[(3R,4S)-4-hydroxyoxolan-3-yl]-1-phenylpyrazole-3-carboxamide (CID 126963049) is 5-[(2,4-dichloro-5-pyridin-2-ylbenzoyl)amino]-N-[(3R,4S)-4-hydroxyoxolan-3-yl]-1-phenylpyrazole-3-carboxamide.
What is the SMILES notation for 5-[(2,4-dichloro-5-pyridin-2-ylbenzoyl)amino]-N-[(3R,4S)-4-hydroxyoxolan-3-yl]-1-phenylpyrazole-3-carboxamide?
The canonical SMILES for 5-[(2,4-dichloro-5-pyridin-2-ylbenzoyl)amino]-N-[(3R,4S)-4-hydroxyoxolan-3-yl]-1-phenylpyrazole-3-carboxamide is O=C(N[C@@H]1COC[C@H]1O)c1cc(NC(=O)c2cc(-c3ccccn3)c(Cl)cc2Cl)n(-c2ccccc2)n1.
What is the InChIKey of 5-[(2,4-dichloro-5-pyridin-2-ylbenzoyl)amino]-N-[(3R,4S)-4-hydroxyoxolan-3-yl]-1-phenylpyrazole-3-carboxamide?
The InChIKey is UFTQWQVOZWPVKL-DHIUTWEWSA-N. The full InChI is InChI=1S/C26H21Cl2N5O4/c27-18-11-19(28)17(10-16(18)20-8-4-5-9-29-20)25(35)31-24-12-21(26(36)30-22-13-37-14-23(22)34)32-33(24)15-6-2-1-3-7-15/h1-12,22-23,34H,13-14H2,(H,30,36)(H,31,35)/t22-,23-/m1/s1.
What are the key properties of 5-[(2,4-dichloro-5-pyridin-2-ylbenzoyl)amino]-N-[(3R,4S)-4-hydroxyoxolan-3-yl]-1-phenylpyrazole-3-carboxamide?
5-[(2,4-dichloro-5-pyridin-2-ylbenzoyl)amino]-N-[(3R,4S)-4-hydroxyoxolan-3-yl]-1-phenylpyrazole-3-carboxamide has a molecular weight of 538.39 g/mol, XLogP of 3.98, 6 rotatable bonds, 3 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[(2,4-dichloro-5-pyridin-2-ylbenzoyl)amino]-N-[(3R,4S)-4-hydroxyoxolan-3-yl]-1-phenylpyrazole-3-carboxamide is sourced from PubChem (CID 126963049), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).